Abstract:Aims/Introduction: Diabetic kidney disease (DKD) is defined as diabetes with impaired renal function, elevated urinary albumin excretion, or both. DKD is one of the most common microvascular complications of diabetes and plays an important role in the cause of end-stage renal disease (ESRD). About 5% of people with type 2 diabetes (T2DM) already have kidney damage at the time they are diagnosed, but other triggers of renal insufficiency, such as obesity, hyperlipidemia, glomerular atherosclerosis are often present, making it difficult to define "diabetic kidney disease" or "diabetic nephropathy" precisely in epidemiology or clinical practice. Therefore, the aim of this study is to identify diabetic patients with CKD at an early stage, and evaluate the value of tubular injury markers including α1-microglobulin (α1-MG), β2-microglobulin (β2-MG), N-acetyl-beta-D-glucosaminidase (NAG) and Urinary retinol binding protein (URBP) in the development of diabetes to DKD. Materials and methods: We recruited a total of 182 hospitalized patients with T2DM in the First Affiliated Hospital of Zhengzhou University from February 2018 to April 2023. We collected basic clinical characteristics and laboratory biochemical parameters of the patients. Based on their levels of urinary albumin creatinine ratio (UACR) and glomerular filtration rate (GFR), patients were divided into DM group (UACR≤30 mg/g and eGFR≥90 mL/min/1.73 m2, n = 63) and DKD group (UACR>30 mg/g or eGFR<90 mL/min/1.73 m2, n = 119) excluding other causes of chronic kidney disease. We further developed diagnostic models to improve the ability to predict the risk of developing DKD by screening potential risk factors using univariate and multivariate logistic regression analysis. Calibration plots and curve analysis were used to validate the model and clinical usefulness. Next, we screened patients with relatively normal estimated glomerular filtration rate (eGFR) (≥90 mL/min/1.73 m2) to investigate whether tubular injury markers could accurately predict the risk of DKD in patients with normal renal function. We defined the rate of GFR decline as a prognostic indicator of renal function in patients and collected the information of the re-hospitalized DKD patients to determine whether the relevant indicators had an impact on the renal prognosis. Results: The patients with DKD had higher levels of tubular injury markers than patients with DM. URBP, α1-MG, eGFR were statistically different in both univariate and multivariate logistic regression analyses and displayed great predictive power after modeling with an area under curve of 0.987. The calibration curve showed medium agreement. Decision curve showed it would add more net benefits for clinical decision. After adjusting eGFR and serum creatinine (Scr), URBP was demonstrated to be associated with early renal function impairment. Conclusion: Tubular injury markers play an important role in early diabetic renal function impairment.

Clinical significance of the combined detection of Cys-C andβ2-MG in prognosis of early diabetic nephropathy

Detection of TNF-α,IL-18 and ADPN in Type 2 Diabetic Patients with Nephropathy

Clinical Significance of Determination of Serum Cystatin C,lipoprotein (α) and High Sensitivity C-reactive Protein in Type 2 Diabetic Patients with Early Renal Impairment.

Application value of DD ,Fib ,Hcy and Cys-C in early diagnosis of type 2 diabetic nephropathy

Clinical significance of detection of serum homocysteine, lipoprotein α, cystatin C,high sensitivity C - reactive protein in diabetic nephropathy patients

Comparison of Diagnostic Value in Early Diabetic Nephropathy among Three Kinds of Glomerular Nitration Rate Estimation Equations

Significance of Special Serum and Urinary Proteins in Early Diagnosis of Diabetic Nephropathy

DIAGNOSTIC VALUE OF URINARY β2-MICROGLOBULIN IN PATIENTS WITH DIABETIC NEPHROPATHY

Evaluating new biomarkers for diabetic nephropathy: Role of α2-macroglobulin, podocalyxin, α-L-fucosidase, retinol-binding protein-4, and cystatin C

Clinical Characteristics of Diabetic Nephropathy in Patients with Type 2 Diabetic Mellitus Manifesting Heavy Proteinuria: a Retrospective Analysis of 220 Cases.

Role of Beta Trace Protein and Cystatin C as a Potential Biomarker for Early Detection of Type 2 Diabetic Nephropathy

Diagnostic value of α1-MG and URBP in early diabetic renal impairment

Detection of glycated albumin and its related metabolic markers in patients with type 2 diabetes mellitus or diabetic nephropathy and clinical significance

Application of urinary N-acetyl-β-D-glucosaminidase combined with serum retinol-binding protein in early detection of diabetic nephropathy

Correlation of cystatin C and diabetic retinopathy in type 2 diabetic patients

Clinical significance of combined detection of plasma CD146 and P-selectin in patients with type 2 diabetic nephrophathy

Diagnostic value of urine microalbuminuria in early renal damage of type 2 diabetic nephropathy

The significance of urinary neutrophil gelatinase-associated lipocalin in the early diagnosis of diabetic nephropathy

The effects of 2-MG, RBP, and CRP on the diagnosis and prediction of the treatment outcomes of diabetic microangiopathy

Combined detection of urinary biomarkers noninvasively predicts extent of renal injury in patients with early diabetic kidney disease with kidney qi deficiency syndrome: A retrospective investigation

The clinical significance of detection of the level of blood HbA1c,urine mAlband β2MG in the early renal damage of DM